BMRN Charles Greg Guyer sells $501K worth of shares
Mar 08, 2025, 5:31 AM
0.00%
What does BMRN do
BioMarin Pharmaceutical, headquartered in San Rafael, California, develops therapies for serious rare diseases and employs 3,401 people. Its products include Vimizim, Roctavian, and Voxzogo for various medical conditions.
Charles Greg Guyer sold 7,034 shares of BMRN on 6 March at $71.28 per share, worth a total of $501K. They now own 87,655 BMRN shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
